• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病中肿瘤和正常“姐妹”淋巴母细胞系的分子特征。

Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.

机构信息

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

出版信息

Leuk Lymphoma. 2013 Aug;54(8):1769-79. doi: 10.3109/10428194.2013.764418. Epub 2013 Feb 25.

DOI:10.3109/10428194.2013.764418
PMID:23297799
Abstract

Chronic lymphocytic leukemia (CLL) B-cells resemble self-renewing CD5 + B-cells carrying auto/xeno-antigen-reactive B-cell receptors (BCRs) and multiple innate pattern-recognition receptors, such as Toll-like receptors and scavenger receptors. Integration of signals from BCRs with multiple surface membrane receptors determines whether the cells will be proliferating, anergic or apoptotic. To better understand the role of antigen in leukemogenesis, CLL cell lines producing monoclonal antibodies (mAbs) will facilitate structural analysis of antigens and supply DNA for genetic studies. We present here a comprehensive genotypic and phenotypic characterization of available CLL and normal B-cell-derived lymphoblastoid cell lines (LCLs) from the same individuals (n = 17). Authenticity and verification studies of CLL-patient origin were done by IGHV sequencing, fluorescence in situ hybridization (FISH) and DNA/short tandem repeat (STR) fingerprinting. Innate B-cell features, i.e. natural Ab production and CD5 receptors, were present in most CLL cell lines, but in none of the normal LCLs. This panel of immortalized CLL-derived cell lines is a valuable reference representing a renewable source of authentic Abs and DNA.

摘要

慢性淋巴细胞白血病 (CLL) B 细胞类似于自我更新的 CD5+携带自身/异抗原反应性 B 细胞受体 (BCR) 的 B 细胞,并且具有多种先天模式识别受体,例如 Toll 样受体和清道夫受体。BCR 与多种细胞膜受体的信号整合决定了细胞是增殖、无能还是凋亡。为了更好地了解抗原在白血病发生中的作用,产生单克隆抗体 (mAb) 的 CLL 细胞系将有助于抗原的结构分析,并提供用于遗传研究的 DNA。我们在此介绍了来自同一个体的可用 CLL 和正常 B 细胞衍生的淋巴母细胞系 (LCL) 的全面基因和表型特征 (n=17)。通过 IGHV 测序、荧光原位杂交 (FISH) 和 DNA/短串联重复 (STR) 指纹分析对 CLL 患者来源进行了真实性和验证研究。大多数 CLL 细胞系都存在先天 B 细胞特征,即天然 Ab 产生和 CD5 受体,但在正常 LCL 中均不存在。该 panel 永生化的 CLL 衍生细胞系是一个有价值的参考,代表了可再生的真实 Abs 和 DNA 来源。

相似文献

1
Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.慢性淋巴细胞白血病中肿瘤和正常“姐妹”淋巴母细胞系的分子特征。
Leuk Lymphoma. 2013 Aug;54(8):1769-79. doi: 10.3109/10428194.2013.764418. Epub 2013 Feb 25.
2
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.具有定型B细胞受体的慢性淋巴细胞白血病的分子和临床特征:一项意大利多中心研究的结果
Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19.
3
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.未突变和突变的慢性淋巴细胞白血病源自自身反应性B细胞前体,尽管它们表达不同的抗体反应性。
J Clin Invest. 2005 Jun;115(6):1636-43. doi: 10.1172/JCI24387. Epub 2005 May 2.
4
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.慢性淋巴细胞白血病中IGHV基因的插入和缺失:具有定型受体的部分病例中的“CLL偏向性”缺失
Eur J Immunol. 2006 Jul;36(7):1963-74. doi: 10.1002/eji.200535751.
5
Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.类似慢性淋巴细胞白血病的CD5阴性B细胞慢性淋巴细胞增殖性疾病的临床和表型特征
Int J Hematol. 2015 Jan;101(1):67-74. doi: 10.1007/s12185-014-1703-y. Epub 2014 Nov 29.
6
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.慢性淋巴细胞白血病中基因与miRNA表达谱和定型亚群#4 B细胞受体之间的关联
Leuk Lymphoma. 2015;56(11):3150-8. doi: 10.3109/10428194.2015.1028051. Epub 2015 May 18.
7
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.TCL1转基因小鼠中的B细胞受体与侵袭性、难治性人类慢性淋巴细胞白血病的B细胞受体相似。
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11713-8. doi: 10.1073/pnas.0604564103. Epub 2006 Jul 24.
8
Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.单个慢性淋巴细胞白血病克隆内CD5表面表达水平的动态变化。
Exp Hematol. 2017 Feb;46:31-37.e10. doi: 10.1016/j.exphem.2016.09.010. Epub 2016 Sep 28.
9
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者亚群中存在显著相似的抗原受体。
J Clin Invest. 2004 Apr;113(7):1008-16. doi: 10.1172/JCI19399.
10
Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.具有受限免疫球蛋白基因重排特征的亚群表明抗原选择在慢性淋巴细胞白血病发展中起作用。
Blood. 2004 Nov 1;104(9):2879-85. doi: 10.1182/blood-2004-01-0132. Epub 2004 Jun 24.

引用本文的文献

1
culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.白血病细胞在胶原蛋白支架和羧甲基纤维素-聚乙二醇凝胶中的培养
PeerJ. 2024 Dec 6;12:e18637. doi: 10.7717/peerj.18637. eCollection 2024.
2
Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance.姜黄素、氟达拉滨和伊布替尼体外联合治疗慢性淋巴细胞白血病干细胞样细胞群的持续存在:对治疗耐药性的影响。
Int J Mol Sci. 2024 Feb 7;25(4):1994. doi: 10.3390/ijms25041994.
3
Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines.
Toll 样受体 9 信号通路在慢性淋巴细胞白血病细胞系中的作用。
FEBS Open Bio. 2023 Dec;13(12):2367-2374. doi: 10.1002/2211-5463.13726. Epub 2023 Nov 8.
4
Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.慢性淋巴细胞白血病中肿瘤抑制性长链非编码RNA BM742401的表观遗传沉默
Oncotarget. 2016 Dec 13;7(50):82400-82410. doi: 10.18632/oncotarget.12252.
5
Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia.依鲁替尼诱导慢性淋巴细胞白血病细胞凋亡的细胞内在决定因素
Clin Cancer Res. 2017 Feb 15;23(4):1049-1059. doi: 10.1158/1078-0432.CCR-15-2921. Epub 2016 Aug 17.
6
Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.白血病细胞上聚糖的不同表达水平——一种以唾液酸为靶点的分子印迹聚合物(MIP)新型筛选方法
Tumour Biol. 2016 Oct;37(10):13763-13768. doi: 10.1007/s13277-016-5280-y. Epub 2016 Jul 31.
7
Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.肿瘤抑制因子miR-3151的表观遗传沉默通过持续激活MADD/ERK和PIK3R2/AKT信号通路,促进中国慢性淋巴细胞白血病的发生发展。
Oncotarget. 2015 Dec 29;6(42):44422-36. doi: 10.18632/oncotarget.6251.
8
Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.新型CD5 +慢性淋巴细胞白血病细胞系PCL12的建立与鉴定
PLoS One. 2015 Jun 25;10(6):e0130195. doi: 10.1371/journal.pone.0130195. eCollection 2015.
9
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.有机金属核苷诱导非经典白血病细胞死亡,这种死亡依赖于线粒体活性氧,并由TCL1癌基因负荷促进。
Mol Cancer. 2015 Jun 4;14:114. doi: 10.1186/s12943-015-0378-1.
10
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.EVI1 与 TCL1A 癌基因的调控相互作用影响 CLL 中的细胞存活和临床结果。
Leukemia. 2015 Oct;29(10):2003-14. doi: 10.1038/leu.2015.114. Epub 2015 May 4.